Emcure Launches Once-Weekly Semaglutide for Weight Management in India MM Desk 23 December, 2025 Emcure Pharmaceuticals Ltd (BSE: 544210 | NSE: EMCURE) has announced the nationwide commercial rollout of Read More
Emcure Pharmaceuticals Reports Robust Growth in Q2 FY2025 MM Desk 12 November, 2025 Emcure Pharmaceuticals Ltd (BSE: 544210, NSE: EMCURE) announced its consolidated financial results for the quarter Read More
Emcure Pharmaceuticals Reports Impressive Q1 FY26 Results with 16% Revenue Rise and 41% Surge in Profit After Tax MM Desk 8 August, 2025 Pune-based Emcure Pharmaceuticals has announced its consolidated financial results for the quarter ending June 30, Read More
Emcure Pharmaceuticals Reports Strong Q4 FY25 Results with 19% Revenue Growth and 63% Increase in Profit After Tax MM Desk 23 May, 2025 Emcure Pharmaceuticals has announced its consolidated financial results for the fourth quarter and full year Read More